3F9M
Human pancreatic glucokinase in complex with glucose and activator showing a mobile flap
3F9M の概要
エントリーDOI | 10.2210/pdb3f9m/pdb |
関連するPDBエントリー | 1V4S 1V4T |
分子名称 | Glucokinase, alpha-D-glucopyranose, 2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE, ... (4 entities in total) |
機能のキーワード | glucokinase, hexokinase iv, atp-binding, diabetes mellitus, disease mutation, glycolysis, kinase, nucleotide-binding, transferase |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 53525.75 |
構造登録者 | Petit, P.,Gluais, L.,Lagarde, A.,Vuillard, L.,Boutin, J.A.,Ferry, G. (登録日: 2008-11-14, 公開日: 2008-12-02, 最終更新日: 2023-11-01) |
主引用文献 | Petit, P.,Antoine, M.,Ferry, G.,Boutin, J.A.,Lagarde, A.,Gluais, L.,Vincentelli, R.,Vuillard, L. The active conformation of human glucokinase is not altered by allosteric activators Acta Crystallogr.,Sect.D, 67:929-935, 2011 Cited by PubMed Abstract: Glucokinase (GK) catalyses the formation of glucose 6-phosphate from glucose and ATP. A specific feature of GK amongst hexokinases is that it can cycle between active and inactive conformations as a function of glucose concentration, resulting in a unique positive kinetic cooperativity with glucose, which turns GK into a unique key sensor of glucose metabolism, notably in the pancreas. GK is a target of antidiabetic drugs aimed at the activation of GK activity, leading to insulin secretion. Here, the first structures of a GK-glucose complex without activator, of GK-glucose-AMP-PNP and of GK-glucose-AMP-PNP with a bound activator are reported. All these structures are extremely similar, thus demonstrating that binding of GK activators does not result in conformational changes of the active protein but in stabilization of the active form of GK. PubMed: 22101819DOI: 10.1107/S0907444911036729 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.5 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード